Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENXBIO Inc. | Chief Medical Officer | Common Stock | 166K | $2.48M | $15.00 | Aug 1, 2024 | Direct |
REGENXBIO Inc. | Chief Medical Officer | Stock Options (Right to Buy) | 31.3K | Mar 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGNX | REGENXBIO Inc. | Aug 1, 2024 | 1 | $0 | 4 | Aug 5, 2024 | Chief Medical Officer |
RGNX | REGENXBIO Inc. | Mar 5, 2024 | 3 | -$78.7K | 4 | Mar 7, 2024 | Chief Medical Officer |
RGNX | REGENXBIO Inc. | Jan 2, 2024 | 4 | -$486K | 4 | Jan 4, 2024 | Chief Medical Officer |
RGNX | REGENXBIO Inc. | Jan 3, 2023 | 4 | -$111K | 4 | Jan 5, 2023 | Chief Medical Officer |
RGNX | REGENXBIO Inc. | Jan 1, 2022 | 4 | -$91.6K | 4 | Jan 4, 2022 | Chief Medical Officer |